Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Fatty acids intake with emphasis on trans fatty acids and risks of Breast cancer and Colorectal Cancer | Paolo Boffetta | The Department of Medical and Surgical Sciences (DIMEC), the University of Bologna | PLCO | Aug 22, 2022 | PLCO-1018 |
AI cancer detection project | TAEHEE KIM | Radisen Co.Ltd. | PLCO | Aug 22, 2022 | PLCOI-1022 |
Labeling and identification of pulmonary nodules | kun tie | BEIJING HEALTHINGKON TECHNOLOGY CO.LTD | NLST | Aug 22, 2022 | NLST-947 |
Mitigating measurement error and missing data impact on analysis of food frequency questionnaire data using machine learning methods | Jennifer Frediani | Emory University | IDATA | Aug 22, 2022 | IDATA-56 |
A systematic evaluation of dietary and behavioral factors associated with renal cell carcinoma risk and survival | Xin Xu | First Affiliated Hospital, School of Medicine, Zhejiang University | PLCO | Aug 9, 2022 | PLCO-1020 |
The interaction effects of genetic susceptibility and biliary tract diseases and the incidence of gastrointestinal cancer | Ci Song | Nanjing Medical University | PLCO | Aug 4, 2022 | PLCO-1016 |
Image quality assessment of digitized chest X ray images | Tomoki Nakamizo | Radiation Effects Research Foundation | PLCO | Aug 4, 2022 | PLCOI-1017 |
Association of the oral microbiome with breast cancer incidence | Emily Vogtmann | National Cancer Institute | PLCO | Aug 2, 2022 | 2022-0007 |
Bladder Cancer Data Visualization | OMAR GALDAMEZ CRUZ | CENTRO DE DISEÑO Y COMUNICACION, S.C. | PLCO | Aug 2, 2022 | PLCO-1011 |
Prognostic factors in HER2-positive breast cancer | Reem Chamseddine | Weill Cornell Medicine-Qatar | PLCO | Aug 2, 2022 | PLCO-1014 |
Clarifying the relationship between body mass index and lung cancer using causal inference methods | Rajat Das Gupta | University of South Carolina | PLCO | Aug 2, 2022 | PLCO-1010 |
Dietary Intake of Phytoestrogens and Risk of Pancreatic Cancer in the PLCO Trial | Chunliang Liu | Second Hospital of Shanxi Medical University | PLCO | Aug 2, 2022 | PLCO-1009 |
A semi-supervised deep clustering framework for personalized post-test risk-stratification in lung cancer screening | Stefano Diciotti | Department of Electrical, Electronic, and Information Engineering "Guglielmo Marconi" (DEI), Alma Mater Studiorum - University of Bologna | NLST | Aug 2, 2022 | NLST-942 |
A Phase II extension of the use of cg05575921 Methylation to predict risk for lung cancer | Robert Philibert | Behavioral Diagnostics | PLCO | Aug 1, 2022 | 2022-0014 |
Characterization of serum immuno-oncology biomarker levels in PLCO participants with mosaic chromosomal alterations | Mitchell Machiela | National Cancer Institute | PLCO | Aug 1, 2022 | 2022-0022 |
Survival Analysis and the Effect of Censoring for Lung Cancer | Azar Shahraz | AstraZeneca | PLCO | Jul 22, 2022 | PLCO-991 |
Academic Research using Deep Learning of PLCO's Lung data | Zean Liu | Harbin Institute of Technology | PLCO | Jul 22, 2022 | PLCO-1008 |
Deep learning based prognosis prediction for lung cancer patients | Danqing Hu | Zhejiang lab | PLCO | Jul 22, 2022 | PLCOI-1005 |
Development and validation of a survival model for lung cancer using pathological images | Zhangxin Zhao | Southern Medical University | NLST | Jul 22, 2022 | NLST-940 |
Deep learning based lymph node metastasis and prognosis prediction for lung cancer | Danqing Hu | Zhejiang lab | NLST | Jul 22, 2022 | NLST-939 |